Products and methods for gaucher disease therpy
OwnerDon J. Mahuran, Joe T.R. Clarke +1inventors
InventorsDon J. Mahuran, Joe T.R. Clarke, John W. Callahan
Life of this patent
Estimating the term…
Abstract
The invention relates to products and methods for medical treatment of Gaucher disease and, in particular, an improved Gcc DNA for insertion into any applicable expression vector for gene therapy treatment. The invention includes an isolated Gcc DNA molecule, wherein nucleic acid molecules have been modified at cryptic splice sites to prevent or decrease splicing of mRNA produced from the DNA molecule, while preserving the ability of the DNA to express functional Gcc polypeptides.
Claims22
An isolated Gcc DNA molecule, wherein the DNA molecule has a modification in at least one nucleotide that disrupts a splicing consensus sequence and prevents splicing of mRNA produced from the DNA molecule, while preserving the ability of the DNA to express active Gcc.
Dependencies are inferred from the claim text.